Synthetic and Natural Cannabinoids: the Cardiovascular Risk

Synthetic and Natural Cannabinoids: the Cardiovascular RiskFrom The British Journal of Cardiology, this 2015 editorial, by neurologist and cannabis research pioneer Dr. Ethan Russo, explores the cardiovascular risks associated with cannabis, suggesting that ultra-low THC and therapeutic phytocannabinoid dosing are cardio protective, while high doses of THC and high levels of stimulation of the CB1 receptor pose cardiovascular risks. (more…)

Research Pioneer: Ethan Russo MD

ethan-russo2

Ethan Russo, MD, is a board-certified neurologist and psychopharmacology researcher. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, in Medicine at the University of Washington, and as visiting professor, Chinese Academy of Sciences. He is currently Past-President of the International Cannabinoid Research Society, and is former Chairman of the International Association for Cannabinoid Medicines. (more…)